DBV Technologies S.A. (DBVT)
NASDAQ: DBVT · Real-Time Price · USD
20.10
+0.61 (3.13%)
At close: May 6, 2026, 4:00 PM EDT
20.30
+0.20 (1.00%)
Pre-market: May 7, 2026, 7:08 AM EDT
DBV Technologies Employees
DBV Technologies had 117 employees as of September 30, 2025. The number of employees increased by 9 or 8.33% compared to the same quarter last year.
Employees
117
Change
9
Growth
8.33%
Revenue / Employee
$49,026
Profits / Employee
-$1,431,171
Market Cap
1.20B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Sep 30, 2025 | 117 | 9 | 8.33% | 117 | 0 |
| Jun 30, 2025 | 109 | 3 | 2.83% | 109 | 0 |
| Mar 31, 2025 | 106 | 1 | 0.95% | 106 | 0 |
| Dec 31, 2024 | 110 | 5 | 4.76% | 109 | 1 |
| Sep 30, 2024 | 108 | 11 | 11.34% | 108 | 0 |
| Jun 30, 2024 | 106 | 18 | 20.45% | 106 | 0 |
| Mar 31, 2024 | 105 | 17 | 19.32% | 105 | 0 |
| Dec 31, 2023 | 105 | 19 | 22.09% | 104 | 1 |
| Sep 30, 2023 | 97 | 12 | 14.12% | 97 | 0 |
| Jun 30, 2023 | 88 | 1 | 1.15% | 88 | 0 |
| Mar 31, 2023 | 88 | 0 | - | 88 | 0 |
| Dec 31, 2022 | 86 | -6 | -6.52% | 85 | 1 |
| Sep 30, 2022 | 85 | -7 | -7.61% | 85 | 0 |
| Jun 30, 2022 | 87 | -10 | -10.31% | 87 | 0 |
| Mar 31, 2022 | 88 | -16 | -15.38% | 88 | 0 |
| Dec 31, 2021 | 92 | -50 | -35.21% | 92 | 0 |
| Sep 30, 2021 | 92 | -219 | -70.42% | 92 | 0 |
| Jun 30, 2021 | 97 | -214 | -68.81% | 97 | 0 |
| Mar 31, 2021 | 104 | -207 | -66.56% | 104 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Pharming Group | 407 |
| UroGen Pharma | 291 |
| EyePoint | 214 |
| Zenas BioPharma | 167 |
| MoonLake Immunotherapeutics | 130 |
| Septerna | 130 |
| Inventiva | 77 |
| Jade Biosciences | 55 |
DBVT News
- 2 days ago - DBVT Reiterated by Guggenheim -- Price Target Maintained at $51.00 - GuruFocus
- 5 days ago - DBVT Maintained by Citizens -- Price Target Raised to $55.00 - GuruFocus
- 6 days ago - DBVT SWOT Analysis: Financial Challenges and Growth Potential Revealed in 10-Q Filing - GuruFocus
- 6 days ago - Is DBV Technologies (DBVT) Fairly Valued After Q1 2026 Results? EPS $(0. ... - GuruFocus
- 6 days ago - DBVT Advances Peanut Allergy Treatments with Upcoming Clinical Studies - GuruFocus
- 6 days ago - DBV Technologies Reports First Quarter 2026 Financial Results - GlobeNewsWire
- 4 weeks ago - DBV Technologies S.A.: Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of March 31, 2026 - Finanz Nachrichten
- 4 weeks ago - Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of March 31, 2026 - GlobeNewsWire